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Introduction
Cardiac magnetic resonance (CMR) is used in the evalua-
tion of acute coronary syndrome (ACS) to assess both area
at risk (AaR) and area of necrosis. However, the time
course and evolution of myocardial oedema in patients
with ACS is not known. We sought to assess the change in
myocardial oedema following percutaneous coronary
intervention (PCI) in patients with ST-elevation myocar-
dial infarction (STEMI) and non-ST elevation ACS (NSTE-
ACS).
Methods
Patients admitted with NSTE-ACS who underwent PCI
within 24 hours, or with STEMI were imaged using CMR
(Siemens Trio 3 T) at 24-48 hours (E1) and 5-7 days (E2)
post PCI. STEMI patients were also imaged at 14-17 days
(E3). The imaging protocol included short axis images
covering the entire left ventricle (LV) acquired using T2-
prepared SSFP sequence and late gadolinium enhance-
ment (LGE). Percentage of myocardial oedema (oedema
area/LV slice area: AaR) and myocardial scar were assessed
offline.
Results
We identified two groups of male patients (6 STEMI and
6 NSTE-ACS) matched for age (54 ± 8 yrs vs 59 ± 13 yrs)
and AaR at E1 (24 ± 15% and 23 ± 14%).
In NSTEMI patients, AaR decreased to 15.6% (p = 0.10)
between E1 and E2. In contrast, in STEMI AaR increased
from 24 ± 15% at E1 to 31 ± 15% 5-7 days post PCI (E2).
By 14-17 days (E3) there was a significant decrease in
oedema (20 ± 13%) in this group.
Myocardial scar assessed by LGE was significantly smaller
in NSTE-ACS compared to STEMI (7 ± 9% vs 21 ± 12%;p
= 0.05), Figure 1.
Conclusion
For equivalent initial area at risk at E1, patients with
STEMI have larger scar and more persistent oedema. Myo-
cardial oedema post PCI decreases in NSTE-ACS within 7
days, but increases in STEMI. These dynamic changes
highlight the importance of CMR in ACS patients and sug-
gest the need to define the optimal time point to assess
area at risk.
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